Shin Yuyeol Takes on Bigger Role...A Bold Bet on "Young Lotte"
Promoted to President Six Years After Joining
To Oversee LOTTE Group's Business Restructuring
Office Heads See Generational Change...Improving Biologics Performance a Key Task
Shin Yuyeol, the eldest son of Lotte Group Chairman Shin Dongbin and head of the Future Growth Office at LOTTE Corporation (vice president, pictured), has been promoted to president, expanding his role across the group's overall management. He will lead the Management Strategy Office, created by expanding and restructuring the former Future Growth Office, and will oversee the group's mid- to long-term strategy and business portfolio adjustments. Having already led the strategy organization at Japan's Lotte Holdings, he will now also head the strategy organization at LOTTE Corporation in Korea and take on the task of fleshing out the "One LOTTE" vision championed by Chairman Shin.
According to industry sources on November 17, Lotte Group held board meetings at 30 affiliates, including LOTTE Corporation, the previous day and carried out its 2027 regular executive appointments. President Shin became president six years after joining Japan's Lotte in 2020 and two years after being promoted to vice president. He will continue to serve as CEO of LOTTE Biologics while also overseeing group strategy and future business operations.
From New Businesses to Group Strategy...Leading Korea-Japan Collaboration
The appointment marks an expansion of President Shin's responsibilities from developing new businesses to shaping the growth direction of the entire group. In addition to existing new business and global business responsibilities, the newly established Management Strategy Office will oversee mid- to long-term strategy, portfolio adjustments, and the AI transformation (AX). In effect, he will hold the reins on the group's direction, including the allocation of resources in line with business restructuring.
President Shin has built up management experience in both Korea and Japan. Born in 1986, he has worked at Nomura Securities, Japan's Lotte, and the Tokyo branch of LOTTE Chemical. At the end of 2023, he was promoted to executive vice president and put in charge of the newly established Future Growth Office. Since 2024, he has also served as head of the Management Strategy Office at Japan's Lotte Holdings. After heading the Global Strategy Office at LOTTE Biologics, he was appointed co-CEO at the end of last year.
In July, he became chair of the board of the Singapore joint venture between LOTTE Wellfood and Japan's Lotte, a company that oversees the two countries' food businesses in Asia. Following his role in biotechnology, he has taken up a position leading Korea-Japan collaboration in food, one of the group's core businesses. This aligns with the "One LOTTE" vision pursued by Chairman Shin. The vision, which came to the fore in 2015 when Chairman Shin became CEO of Japan's Lotte Holdings, has evolved from integrated management across Korea and Japan into a business strategy that combines the two countries' brands and production and distribution networks. The aim is to find new sources of growth overseas in response to slowing growth in domestic markets.
Executives in Their 40s Make Up 44% of Lotte's Promotions...Biologics Results and Food Collaboration Must Deliver
Lotte has also restructured its holding company organization. It is shifting to a model with a single professional manager, CEO Noh Junhyung (president), overseeing the full range of holding company functions, including planning and strategy, finance, and compliance. President Shin will lead the Management Strategy Office within this structure. As his strategic responsibilities expand, the heads of the offices responsible for finance, HR, and management administration, who will work closely with him, have also been replaced. All five newly appointed office heads hold the rank of executive vice president. Their average age is 55.6, two years younger than before. Across the group, 153 executives were promoted, including 86 newly appointed executives; 44% of the newly appointed executives are in their 40s.
His broader responsibilities also bring greater pressure. President Shin's top priority is improving the performance of the biologics business, which he directly leads. Lotte said it recognized his contributions in leading the completion of Plant 1 at the Songdo Bio Campus, preparations for commercial production, and securing production orders for the Syracuse campus in the United States. He is now tasked with turning this expanded production capacity into revenue and profit. According to LOTTE Corporation's quarterly report, LOTTE Biologics' consolidated revenue from January through September this year was 48.5 billion won, down 68.6% from the same period a year earlier. Its operating loss widened from 53 billion won to 176.9 billion won.
The company has set next year as the first year of full-scale revenue growth, following upgrades to its Syracuse facilities and validation of its Songdo production facilities. As of the report's submission date, the total value of antibody drug orders, including additional contracts, stood at a minimum of $822.9 million based on minimum order volumes. The key will be to turn secured contracts into actual production and stabilize operations at both sites.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Another challenge is demonstrating Chairman Shin's management vision. The Singapore food joint venture must boost cross-selling of products and improve profitability through joint procurement and research and development, as well as links between production and logistics networks. An industry source said, "Given that he is taking charge of the strategy organizations at both holding companies, he needs to set investment priorities and the direction of business restructuring. The ability to translate those decisions into revenue and profit will be the measure of his management capabilities."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.